Physician profile
Vikas Pathak
NPI 1740474121
$31,571.78
in general payments reported to CMS, 2019-2025
33 companies · $3,537 in 2025
The $3,537 reported for 2025 was more than what 85% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,761 · 2020: $15K · 2021: $7,644 · 2022: $150 · 2024: $3,699 · 2025: $3,537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Travel and Lodging: $913 · Food and Beverage: $823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Travel and Lodging | $912.57 |
| Food and Beverage | $823.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $12,184.04 | 2020-2024 | Ofev |
| Mylan Specialty L.P. | $8,626.43 | 2019-2021 | |
| Intuitive Surgical, INC. | $6,582.92 | 2022-2025 | |
| Pulmonx Corporation | $1,205.64 | 2019-2024 | Chartis Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Olympus Corporation of The Americas | $1,094.34 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $203.31 | 2020-2024 | Uptravi |
| Pinnacle Biologics, INC | $200.00 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $190.26 | 2019-2025 | Tagrisso, Fasenra, Airsupra |
| Glaxosmithkline, LLC. | $175.53 | 2019-2025 | Nucala |
| Janssen Pharmaceuticals, INC | $135.77 | 2020-2022 | |
| Edwards Lifesciences Corporation | $126.87 | 2025 | Sapien 3 Ultra Resilia |
| Abbvie INC. | $72.26 | 2025 | |
| Paratek Pharmaceuticals, INC. | $64.63 | 2021-2024 | Nuzyra |
| United Therapeutics Corporation | $62.69 | 2020-2025 | Tyvaso |
| Novartis Pharmaceuticals Corporation | $57.39 | 2019-2020 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $57.36 | 2019-2025 | Smartvest |
| Insmed, INC. | $52.71 | 2024-2025 | Arikayce |
| Jazz Pharmaceuticals INC. | $50.64 | 2020-2021 | |
| Grifols USA, LLC | $46.29 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $44.79 | 2019-2021 | |
| Abbott Laboratories | $41.38 | 2024 | |
| Boston Scientific Corporation | $39.72 | 2024 | Ekosonic |
| Takeda Pharmaceuticals U.S.A., INC. | $33.94 | 2025 | Glassia |
| Shire North American Group INC | $31.94 | 2019 | |
| Melinta Therapeutics, LLC | $31.47 | 2025 | Rezzayo |
| Bard Access Systems, INC. | $28.28 | 2019 | |
| Bard Peripheral Vascular, INC. | $26.78 | 2025 | Peritx |
| Allergan, INC. | $20.92 | 2019 | |
| Sunovion Pharmaceuticals INC. | $20.63 | 2019 | |
| Harmony Biosciences LLC | $18.28 | 2021 | |
| Pfizer INC. | $17.94 | 2025 | |
| Merck Sharp & Dohme LLC | $13.40 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikas Pathak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.